Results 211 to 220 of about 669,987 (295)

Federated microservices architecture with blockchain for privacy-preserving and scalable healthcare analytics. [PDF]

Sci Rep
Harshith M, Ansari ZA, Fatima S, Siddiqui S, Swarna S, Reddy DRN, Mohsin SW.   +6 more
europepmc   +1 more source

STAFF RESPONSES TO CHALLENGING BEHAVIOUR: AN EVALUATION OF BEHAVIOUR ANALYTIC CONCEPTS AND INTERVENTION STRATEGIES

, 1997
Neil Bathurst
openalex   +2 more sources

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Antecedents of data analytics adoption: A systematic literature review from 2018-2024. [PDF]

F1000Res
Husni A, Madurapperuma W, Thilini Sumudu Kumari RD.   +2 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Editorial: Insights (March 2018)

Technology Innovation Management Review, 2018
Chris McPhee
doaj  

ShinyEvents: harmonizing longitudinal data for real-world survival estimation. [PDF]

NPJ Precis Oncol
Obermayer A, Davis J, Talada DP, Teng M, Eschrich S, Yin V, Spakowicz D, Chatterjee D, Rounbehler RJ, Churchman ML, Tarhini AA, Wang X, Gupta S, Markowitz J, Goecks J, Li R, Rodrigues Pessoa R, Manley BJ, Tan AC, Grass GD, Chen DT, Shaw TI.   +21 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Digital Dissemination Strategies for Health Promotion Videos in Indigenous Communities in California: Protocol for a Three-Arm Comparative Study.

JMIR Res Protoc
Abascal Miguel L, Epperson AE, Comfort AB, León D, Garcia ME, Riley AR, Diamond-Smith N.   +6 more
europepmc   +1 more source

Exploring the Barriers and Opportunities for a More Predictive Data-Driven Telecare Service: Qualitative Study in Scotland. [PDF]

JMIR Form Res
Dunlop E, Kernaghan D, Weir N, Kavanagh K, Roper M, Lennon M.   +5 more
europepmc   +1 more source